Multi-omics and spatial analysis of microgravity-grown glioblastoma organoids reveal superior modeling of advanced disease after long-term spaceflight.

Spaceflight-grown glioblastoma organoids with monocytes show increased expression of genes linked to disease progression and poor patient outcomes, indicating a more advanced disease model.

• Why it matters: Accurate glioblastoma models are crucial for understanding disease mechanisms and developing treatments, but current Earth-based models face limitations like sedimentation and disaggregation, which spaceflight may overcome.
• What they did: The study cultured GBM-myeloid organoids for 40 days aboard the International Space Station, analyzing transcriptional and spatial gene expression, protein secretion, and chemical gradients in space- and ground-grown samples.
• The result: Findings suggest spaceflight enhances modeling of advanced glioblastoma features, with increased aggressive markers and tumor architecture mimicry, supporting the development of orbital oncology research methods.